Table 2 Clinical characteristics of study participants (N = 660)
Characteristic | n | % |
|---|---|---|
Body mass Index Kg/M2 | ||
Underweight | 173 | 26.3 |
Normal | 398 | 60.4 |
Missing (n = 1)a | ||
Overweight | 66 | 10.0 |
Obesity | 22 | 3.3 |
Polyuria | 110 | 16.7 |
Polyphagia | 68 | 10.3 |
Polydipsia | 82 | 12.4 |
Nocturia | 151 | 22.9 |
Loss of weight | 479 | 72.6 |
Fatigue | 375 | 56.8 |
Blurred vision | 100 | 15.2 |
Fasting blood glucose levels in mmol/L (n-635) | ||
Normal | 453 | 71.3 |
Impaired fasting glucose | 147 | 23.1 |
Diabetes | 35 | 5.5 |
Oral glucose tolerance test (n = 147) | ||
Normal | 110 | 74.1 |
Impaired glucose tolerance | 33 | 23.1 |
Diabetes | 4 | 2.8 |
Sputum Acid fast bacilli status | ||
Positive | 398 | 60.3 |
Tuberculosis anatomical site | ||
Pulmonary | 577 | 87.4 |
TB treatment category | ||
First line | 578 | 87.6 |
First line re-treatment | 68 | 10.3 |
Second line | 14 | 2.1 |
Tuberculosis treatment phase | ||
Intensive | 269 | 40.8 |
Continuation | 391 | 59.2 |
HIV sero-status | ||
Positive | 212 | 32.1 |
On HIV treatment | ||
Yes | 191 | 90.1 |